Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level650 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00938470 | Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 73 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT02942329 | Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER |
| 1 |
| Feb 26, 2018 |
| clinicaltrials |
| NCT00183872 | Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 40 | University of Southern CaliforniaOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT03427684 | Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 18 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT03428425 | A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 | 38 | Hebei Medical UniversityOTHER | 0 | Feb 9, 2018 | clinicaltrials |
| NCT01612546 | Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery | completed | Phase 2 | 10 | City of Hope Medical CenterOTHER | 1 | Feb 1, 2018 | clinicaltrials |
| NCT01683864 | Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer(HIPECStomach) | terminated | Phase 2 / Phase 3 | 3 | University Hospital TuebingenOTHER | 1 | Jan 30, 2018 | clinicaltrials |
| NCT03410732 | Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer | unknown | Phase 2 | 120 | LanZhou UniversityOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT03399253 | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor | unknown | Phase 2 / Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT00848783 | Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers | terminated | Phase 2 | 8 | NYU Langone HealthOTHER | 1 | Jan 8, 2018 | clinicaltrials |
| NCT03392103 | Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection | unknown | Phase 2 | 48 | Zhongnan HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT02461407 | Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) | unknown | Phase 2 / Phase 3 | 378 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 29, 2017 | clinicaltrials |
| NCT01178944 | Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 35 | Roswell Park Cancer InstituteOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00201747 | Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer | completed | Phase 2 | 80 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 6, 2017 | clinicaltrials |
| NCT00903396 | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | terminated | Phase 2 | 7 | Alliance for Clinical Trials in OncologyOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT02509806 | Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02510469 | Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03007446 | The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer | unknown | Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT03271073 | A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 20 | Beijing Friendship HospitalOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03258034 | A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer | unknown | Phase 2 | 50 | The First Affiliated Hospital of Zhejiang Chinese Medical UniversityOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT00394433 | Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01406249 | XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 100 | Epidemiological and Clinical Research Information NetworkOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT01412294 | XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer | unknown | Phase 2 | 40 | Epidemiological and Clinical Research Information NetworkOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT02229058 | Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer | completed | Phase 2 | 73 | Sun Yat-sen UniversityOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT01921673 | Dovitinib Plus Docetaxel in Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Asan Medical CenterOTHER | 1 | Jul 14, 2017 | clinicaltrials |
| NCT00062374 | Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jul 6, 2017 | clinicaltrials |
| NCT01774851 | A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach | terminated | Phase 2 | 84 | Merrimack PharmaceuticalsINDUSTRY | 1 | Jun 22, 2017 | clinicaltrials |
| NCT01472029 | Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach(HerFLOT) | completed | Phase 2 | 53 | AIO-Studien-gGmbHOTHER | 1 | Jun 19, 2017 | clinicaltrials |
| NCT01231399 | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | completed | Phase 1 / Phase 2 | 6 | City of Hope Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01355302 | E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer | terminated | Phase 1 / Phase 2 | 7 | Eisai Inc.INDUSTRY | 4 | May 15, 2017 | clinicaltrials |
| NCT02202759 | A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction | terminated | Phase 2 | 38 | Millennium Pharmaceuticals, Inc.INDUSTRY | 4 | May 15, 2017 | clinicaltrials |
| NCT01641939 | A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | terminated | Phase 2 / Phase 3 | 415 | Hoffmann-La RocheINDUSTRY | 28 | May 12, 2017 | clinicaltrials |
| NCT03144843 | Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | unknown | Phase 2 | 110 | Sun Yat-sen UniversityOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT03137004 | Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 47 | Fujian Cancer HospitalOTHER_GOV | 1 | May 8, 2017 | clinicaltrials |
| NCT03044743 | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | unknown | Phase 1 / Phase 2 | 20 | Yang YangOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT02711033 | Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection | unknown | Phase 2 | 144 | Guangdong Provincial Hospital of Traditional Chinese MedicineOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT01152645 | Study of ARQ 197 Monotherapy(ARQ 197-004) | completed | Phase 2 | 31 | Kyowa Kirin Co., Ltd.INDUSTRY | 2 | Mar 15, 2017 | clinicaltrials |
| NCT01457846 | Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer(SHINE) | terminated | Phase 2 | 960 | AstraZenecaINDUSTRY | 16 | Mar 7, 2017 | clinicaltrials |
| NCT02890511 | A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer | completed | Phase 1 / Phase 2 | 28 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT00448682 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery | terminated | Phase 2 | 25 | University of MiamiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01441310 | Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer(SNNS) | completed | Phase 2 | 101 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01441336 | Laparoscopic Gastrectomy for Advanced Gastric Cancer | completed | Phase 2 | 204 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT01938313 | Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy(ERAS) | completed | Phase 2 | 100 | Seoul National University Bundang HospitalOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT02694081 | The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric | unknown | Phase 2 | 100 | Jilin UniversityOTHER | 1 | Jan 2, 2017 | clinicaltrials |
| NCT00054457 | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT02976142 | The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer | unknown | Phase 2 | 150 | Moscow Clinical Scientific CenterOTHER | 0 | Dec 13, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Mar 29, 2018source: clinicaltrials